Mpox outbreaks in Africa could be ended in 6 months, WHO chief says
The head of the World Health Organization believes the ongoing mpox outbreaks in Africa might be stopped in the next six months
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.The head of the World Health Organization believes the ongoing mpox outbreaks in Africa might be stopped in the next six months, and said Friday that the agency's first shipment of vaccines should arrive in Congo within days.
To date, Africa has received just a tiny fraction of the vaccines needed to slow the spread of the virus, especially in Congo, which has the most cases — more than 18,000 suspected cases and 629 deaths.
“With the governments’ leadership and close cooperation between partners, we believe we can stop these outbreaks in the next six months,” WHO Director-General Tedros Adhanom Ghebreyesus said at a press briefing.
He said that while mpox infections have been rising quickly in the last few weeks, there have been relatively few deaths. Tedros also noted there were 258 cases of the newest version of mpox, with patients identified in Burundi, Rwanda, Kenya, Uganda, Sweden and Thailand.
Earlier this month, WHO declared the ongoing mpox outbreaks in Africa a global emergency, hoping to spur a robust global response to the disease on a continent where cases were spreading largely unnoticed for years, including in Nigeria. In May, scientists detected a new version of the disease in Congo that they think could be spreading more easily.
Mpox, also known as monkeypox, is related to smallpox but typically causes milder symptoms, including fever, headache and body aches. In severe cases, people can develop painful sores and blisters on the face, chest, hands and genitals. Mpox is typically spread via close skin-to-skin contact.
WHO estimated about 230,000 vaccines could be sent “imminently” to Congo and elsewhere. The agency said it was also working on education campaigns to raise awareness of how people could avoid spreading mpox in countries with outbreaks.
Maria Van Kerkhove, who directs WHO's epidemic and pandemic diseases department, said the agency was working to expedite vaccine access for affected countries — given the limited supply available.
Scientists have previously pointed out that without a better understanding of how mpox is spreading in Africa, it may be difficult to know how best to use the shots.
Earlier this week, the head of Africa's Centers for Disease Control and Prevention said the continent was hoping to receive about 380,000 doses of mpox vaccines promised by donors, including the U.S. and the European Union. That’s less than 15% of the doses authorities have said are needed to end the mpox outbreaks in Congo.
___
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.